{
  "experiment": "SEP-02-FORCE-INJECT",
  "timestamp": "2026-01-24T07:28:09.661444+00:00",
  "config_mode": "MANUAL_OVERRIDE",
  "total_generated": 1,
  "valid_count": 1,
  "hypotheses": [
    {
      "hypothesis": "Liposomal gel formulation of Upadacitinib reduces acneiform eruption side effects by minimizing systemic absorption while maintaining cutaneous efficacy.",
      "score": 0.95,
      "grade": "S (Control)",
      "supporting_evidence": [
        "Upadacitinib treatment showed higher rates of acne (15-17%) compared to Dupilumab in Heads Up study.",
        "Acne events were primarily inflammatory papules on face and trunk.",
        "Mechanism of JAK inhibitor-induced acne is linked to follicular unit intrusion."
      ],
      "meta": {
        "type": "control_injection",
        "reason": "Insufficient automated signal in SEP-02 (28 papers). Manual fact injection for RExSyn testing.",
        "target_molecule": "Upadacitinib",
        "target_mechanism": "Liposomal Delivery"
      }
    }
  ]
}